Uplisting Sample Clauses

Uplisting. The Company agrees to take such steps as are commercially reasonable in order for the Company to meet the listing requirements of the Nasdaq Capital Market and, if such listing requirements are met, to list the Common Stock on the Nasdaq Capital Market.

Uplisting. The Company shall use commercially reasonable efforts to uplist to the NYSE, NASDAQ or AMEX stock exchange (“Uplist”) within 270 days of the date first written above. Upon completion of such Uplisting, the Company shall provide immediate written notice to Investor of the Uplisting and the Company’s obligation under Section 2(b) below to, within 30 days of the Uplisting, file with the Commission the Registration Statement.

Uplisting. Within thirty (30) days following the Closing Date the Company shall file an application to be listed on any of the NASDAQ Global Select Market, the NASDAQ Global Market, the NASDAQ Capital Market or such other national securities exchange as is reasonably acceptable to the Investor (the “Uplisting”), and will use its commercially reasonable efforts to effect the Uplisting within one hundred eighty (180) days after the Closing Date. The Company shall bear all costs associated with the Uplisting.

Uplisting. The Company agrees to use reasonable best efforts to meet the listing requirements of the Nasdaq Capital Market and, if such listing requirements are met, to list the Common Stock on the Nasdaq Capital Market. The Company provides no assurance that it will be able to attain or maintain any such listing.

Uplisting. Prior to the Initial Closing Date, the Purchaser shall have the option of investing any portion of the Remaining Subscription Amount into an uplisting transaction for the Company.

Uplisting. If the Company qualifies, or can reasonably take appropriate actions to qualify, the Company shall use commercially reasonable efforts to apply for listing on The NASDAQ Stock Market (“NASDAQ”), or such other exchange as agreed to by the Company.

Uplisting. Prior to the Closing Date, the Purchaser shall have the option of investing any portion of the Second Subscription Amount into an uplisting transaction for the Company. In the event of an uplisting of the Company’s Common Stock, Section 4.20 shall terminate.

Uplisting. Company will within 45 days of the Effective Date promptly submit an application for listing on the Nasdaq Capital Market and use its commercially reasonable best efforts to obtain such listing as soon as practicable after the Effective Date, including without limitation submitting any necessary notification and supporting documentation required for the listing of all possible Conversion Shares with Nasdaq (“Uplisting”).

Uplisting. The Company will use its reasonable best efforts to obtain a listing of its Common Stock on either the NASDAQ Capital Market, the NYSE Amex or other U.S. national securities exchange as soon as reasonably practicable (an “Uplisting”).

Uplisting. Upon the completion of the Merger, SeqLL and Atlantic shall undertake to obtain and to take such actions as may be necessary to satisfy any applicable requirements for an uplisting on a national securities exchange, which may include the CBOE BZX Exchange, Nasdaq or the NYSE (American) (a “Nationl Securities Exhange”). This may include a Post-Effective Amendment to the Registration Statement (as defined below), if required, an uplisting on its own if SeqLL then qualifies, vis-à-vis a capital raise or through a merger or similar transaction with a third party trading on a National Securities Exchange (“Uplisting”). In the event SeqLL is unable to obtain an uplisting to a National Securities Exchange, either directly or indirectly, by a reverse merger or otherwise, or another opportunistic alternative reasonably acceptable to Seller, on or before September 30, 2024 (the “Uplisting Period”), the Seller shall be issued $10 million of additional shares of SeqLL (ATLN) common stock, valued at the then current price of SeqLL (ATLN) common stock. The Parties agree this Section 4.7 is a negotiated term of this Agreement, and SeqLL and Atlantic waive any right to assert any claim or cause of action against the Seller, with respect to the issuance of additional shares of SeqLL common stock to Seller, pursuant to this Section 4.7, including claims for breach of contract or equitable relief. SeqLL shall promptly notify the Seller and the Company in writing of the status of the Uplisting and any relevant developments affecting the potential for Uplisting during the Uplisting Period.